MS fatigue fight: which pill works better for daily energy?
NCT ID NCT06843382
Summary
This study aims to see if two common oral medications for multiple sclerosis (MS)—teriflunomide and dimethyl fumarate—differ in how they affect physical and mental fatigue over a year. Researchers will follow 100 adults with MS who are starting one of these medications as part of their regular care, measuring their walking endurance, hand function, and thinking speed at regular check-ups. The goal is to provide real-world evidence to help patients and doctors choose treatments that better manage the debilitating fatigue common in MS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Erciyes University
Kayseri, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.